EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice

John S Riley, Valerie L Luks, Cara L Berkowitz, Ana Maria Dumitru, Nicole J Kus, Apeksha Dave, Pallavi Menon, Monique E De Paepe, Rajan Jain, Li Li, Lorraine Dugoff, Christina Paidas Teefey und 3 weitere

Journal of Clinical Investigation · 2024

DOI: 10.1172/jci179848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von John S Riley und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Dependovirus, Gene Editing. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In utero gene editing (IUGE) is a potential treatment for inherited diseases that cause pathology before or soon after birth. Preexisting immunity to adeno-associated virus (AAV) vectors and Cas9 endonuclease may limit postnatal gene editing. The tolerogenic fetal immune system minimizes a fetal immune barrier to IUGE. However, the ability of maternal immunity to limit fetal gene editing remains a question. We investigated whether preexisting maternal immunity to AAV or Cas9 impairs IUGE. Using a combination of fluorescent reporter mice and a murine model of a metabolic liver disease, we demonstrated that maternal anti-AAV IgG antibodies were efficiently transferred from dam to fetus and impaired IUGE in a maternal titer–dependent fashion. By contrast, maternal cellular immunity was inefficiently transferred to the fetus, and neither maternal cellular nor humoral immunity to Cas9 impaired IUGE. Using human umbilical cord and maternal blood samples collected from mid- to late-gestation pregnancies, we demonstrated that maternal-fetal transmission of anti-AAV IgG was inefficient in midgestation compared with term, suggesting that the maternal immune barrier to clinical IUGE would be less relevant at midgestation. These findings support immunologic advantages for IUGE and inform maternal preprocedural testing protocols and exclusion criteria for future clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DependovirusGene EditingAnimalsFemaleMicePregnancyHumansImmunoglobulin GCRISPR-Associated Protein 9Genetic VectorsMaternal-Fetal ExchangeAntibodies, ViralCRISPR-Cas SystemsFetusImmunity, Maternally-Acquired

Stichwörter der Autor:innen

Gene therapyGenetic diseasesImmunologyTherapeutics

Substanzen

Immunoglobulin GCRISPR-Associated Protein 9Antibodies, Viral

Autor:innen und Institutionen

  • Center for Fetal Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, USA.
  • Division of Cardiology, Department of Medicine, and.
  • Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Center for Fetal Diagnosis and Treatment and.

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • NINDS NIH HHS
  • NICHD NIH HHS
  • NIH Office of the Director
  • NIH, NIDDK
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development
  • American College of Surgeons

Zitieren

APA

Riley, J. S., Luks, V. L., Berkowitz, C. L., Dumitru, A. M., Kus, N. J., Dave, A., Menon, P., De Paepe, M. E., Jain, R., Li, L., Dugoff, L., Teefey, C. P., Alameh, M. G., Zoltick, P. W., & Peranteau, W. H. (2024). Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice. Journal of Clinical Investigation. https://doi.org/10.1172/jci179848

Vancouver

Riley JS, Luks VL, Berkowitz CL, Dumitru AM, Kus NJ, Dave A, et al. Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice. Journal of Clinical Investigation. 2024. doi:10.1172/jci179848

BibTeX
@article{Riley2024,
  author = {Riley, John S and Luks, Valerie L and Berkowitz, Cara L and Dumitru, Ana Maria and Kus, Nicole J and Dave, Apeksha and Menon, Pallavi and De Paepe, Monique E and Jain, Rajan and Li, Li and Dugoff, Lorraine and Teefey, Christina Paidas and Alameh, Mohamad-Gabriel and Zoltick, Philip W and Peranteau, William H},
  title = {Preexisting maternal immunity to AAV but not Cas9 impairs in utero gene editing in mice},
  journal = {Journal of Clinical Investigation},
  year = {2024},
  doi = {10.1172/jci179848}
}
Kostenlos starten →